Contact us todayContact us today

Antibody-Drug Conjugates (ADCs): Navigating Four Pillars of Safety, Development, Supply Chain and Manufacturing Excellence 2023

Antibody-Drug Conjugates (ADCs): Navigating Four Pillars of Safety, Development, Supply Chain and Manufacturing Excellence 2023

Last Updated: September 17, 2024By Dr. Kishore HothaCategories: Publications

Related projects

View all projects

Is Your CDMO Using These Aidriven Solutions in CMC For Oliogs and Peptides?

Rethinking Nitrosamines – Moving Beyond Compliance

Where Biotech Wins: “The Role of CMC Excellence”

Operational Excellence Tools in Pharma & Biotech for Driving Efficiency

Artificial Intelligence (AI) in Drug Development and Regulatory Decisionmaking

CMC Strategies With CDMOs: Ensuring CQAs For Oligos And Peptides

Let’s Make Things Happen

Contact Info

Dr. Hotha’s Life Sciences LLC
30 Longview Circle,
Ayer, MA 01432, USA
contact@drhothas.com
+1-978-501-4938

Dr. Kishore Hotha, PhD, MBA – President, Dr. Hotha Life Sciences LLC

Connect Dr. HothaConnect Dr. Hotha